TrialJournal of clinical immunology2004

Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.

Prabhakar Putheti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.